"Medical Oncology Hematology Consultants, PA is Delaware's largest cancer care center, providing high-quality, evidence-based cancer care and expertise in the diagnsis and treatment of cancers and disorders of the blood."

During the past decade, Medical Oncology Hematology Consultants PA conducted 161 clinical trials. In the 10-year time frame, 161 clinical trials started and 75 clinical trials were completed, i.e. on average, 46.6% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 63 clinical trials were completed. i.e. 80.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology Hematology Consultants PA" #1 sponsor was "National Cancer Institute (NCI)" with 94 trials, followed by "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "SWOG Cancer Research Network" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology" with 17 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Hematology Consultants PA" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology Hematology Consultants PA" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Chronic Lymphocytic Leukemia" (6 trials). Many other conditions were trialed in "Medical Oncology Hematology Consultants PA" in a lesser frequency.

Most popular intervention types in "Medical Oncology Hematology Consultants PA" are "Drug" (175 trials), "Other" (136 trials), "Biological" (75 trials), "Procedure" (57 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (62 trials), "Laboratory Biomarker Analysis" (61 trials), "Questionnaire Administration" (38 trials), "Carboplatin" (26 trials) and "Computed Tomography" (26 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology Hematology Consultants PA" are 180 trials for "All" genders, 31 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Oncology Hematology Consultants PA". undefined are not yet recruiting, 65 are recruiting, 98 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Medical Oncology Hematology Consultants PA, 7 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology Hematology Consultants PA, 6 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 116 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Medical Oncology Hematology Consultants PA has several departments that took part in Clinical trials: "Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center" - 2 trials